Pablo G. Legorreta, CEO, Chairman of the Board at Royalty Pharma plc (RPRX), bought 90,000 shares at $32.78 ($3.0M) on 2023-06-13, disclosed to the SEC on 2023-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.00 | 45,000 | $1.5M | 50.2% |
| 2 | $32.78 | 45,000 | $1.5M | 49.8% |
| Total | $32.89 avg | 90,000 | $3.0M | 100% |
| Filing → |
| RPRX | BUY | 2023-05-24 | $4.8M | — | Filing → |
| RPRX | BUY | 2023-05-17 | $15.4M | — | Filing → |
| RPRX | BUY | 2020-06-22 | $280K | — | Filing → |